Cargando…
Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186)
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822882/ https://www.ncbi.nlm.nih.gov/pubmed/36623957 http://dx.doi.org/10.1016/j.ophtha.2022.11.023 |
_version_ | 1784866036058685440 |
---|---|
author | Pellegrini, Marco Yu, Angeli Christy |
author_facet | Pellegrini, Marco Yu, Angeli Christy |
author_sort | Pellegrini, Marco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9822882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | by the American Academy of Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-98228822023-01-09 Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) Pellegrini, Marco Yu, Angeli Christy Ophthalmology Correspondence by the American Academy of Ophthalmology 2023-04 2023-01-07 /pmc/articles/PMC9822882/ /pubmed/36623957 http://dx.doi.org/10.1016/j.ophtha.2022.11.023 Text en © 2022 by the American Academy of Ophthalmology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Pellegrini, Marco Yu, Angeli Christy Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title | Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title_full | Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title_fullStr | Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title_full_unstemmed | Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title_short | Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis (Ophthalmology. 2023;130:179–186) |
title_sort | re: singh et al.: vaccine-associated uveitis following covid-19 vaccination: vaccine adverse event reporting system database analysis (ophthalmology. 2023;130:179–186) |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822882/ https://www.ncbi.nlm.nih.gov/pubmed/36623957 http://dx.doi.org/10.1016/j.ophtha.2022.11.023 |
work_keys_str_mv | AT pellegrinimarco resinghetalvaccineassociateduveitisfollowingcovid19vaccinationvaccineadverseeventreportingsystemdatabaseanalysisophthalmology2023130179186 AT yuangelichristy resinghetalvaccineassociateduveitisfollowingcovid19vaccinationvaccineadverseeventreportingsystemdatabaseanalysisophthalmology2023130179186 |